Role of sumoylation modification of sirtuin 3 in hypertension-associated

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Sun Runmin

Lanzhou (China)

5 More presentations in this session

Presentation thumbnail

Relationship between fibrosis-4 index and new onset hypertension in the general population

Doctor H. Takase (Hamamatsu, JP)

Abstract Slides Video

Presentation thumbnail

Conditional over-expression of heme-oxygenase 1 in myelomonocytic cells reduces AngII-induced hypertension and vascular inflammation in mice

Professor P. Wenzel (Mainz, DE)

Abstract Slides Video

Presentation thumbnail

The role of IL15 in angiotensin II-mediated cardiac remodelling

Ms E. Booth (Glasgow, GB)

Abstract Slides Video

Presentation thumbnail

Exercise-induced inflammatory and thrombotic acute phase response in hypertensive patients.

Doctor C. Liakos (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Blood pressure polygenic risk scores associate with resistant hypertension in individuals with type 1 diabetes

Doctor H. Sanez Tahtisalo (Helsinki, FI)

Abstract Slides Video

Access the full session

Session thumbnail

Hypertension: biomarkers, genetics, and molecular mechanisms

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

NRF3-mediated mitochondrial superoxide promotes cardiomyocyte apoptosis and impairs cardiac functions by suppressing Pitx2

Congress Presentation

Mitochondrial Oxidative Stress and Cardiac Dysfunction in TERT Knockout Mice

Congress Presentation

Istaroxime and its metabolite analogue reduce reperfusion arrhythmias in isolated-perfused diabetic rat hearts and anesthetized diabetic rats

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources